SCHEMBL3258035

SCHEMBL3258035

COc1cc(Cc2cnc(N)nc2N)c2cc(Cc3c(C(=O)N(C)C)[nH]c4ccc(Cl)cc34)oc2c1OC

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39
SLC22A1 O15245 1/20 0.39
ALDH1A1 P00352 1/20 0.39
DHFR P00374 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
CYP2C19 P33261 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30932949 1.00 SMN1; SMN2 (0.39) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL3250064 0.95 SMN1; SMN2 (0.38) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL14140118 0.93 SMN1; SMN2 (0.40) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL6003796 0.92 SMN1; SMN2 (0.38) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL3255329 0.92 SMN1; SMN2 (0.40) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
Dimethylamine SCHEMBL6003803 0.91 MEN1 (0.44) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL3254522 0.91 SMN1; SMN2 (0.39) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL3258152 0.91 SMN1; SMN2 (0.41) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL3250062 0.90 MEN1 (0.38) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR
SCHEMBL3256001 0.90 SMN1; SMN2 (0.38) SMN1; SMN2MEN1SLC22A1ALDH1A1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4453129-B1 ELECTRONIC DEVICES SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-04 EP claimed
US-20250380610-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2025-12-11 US claimed
CN-118878490-A Deuterated composition, organic electroluminescent device and display device 阜阳欣奕华新材料科技股份有限公司 2024-11-01 CN claimed
EP-4453129-A1 ELECTRONIC DEVICES Merck Patent GmbH (DE) 2024-10-30 EP claimed
CN-118742076-A Organic light emitting device 株式会社LG化学 2024-10-01 CN claimed
WO-2024183732-A1 DEUTERATED COMPOSITION 阜阳欣奕华材料科技有限公司 2024-09-12 WO claimed
CN-118619929-A Deuterated composition 阜阳欣奕华材料科技有限公司 2024-09-10 CN claimed
CN-118496216-A Aromatic amine compound and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2024-08-16 CN claimed
CN-118355092-A Electronic device 默克专利有限公司 2024-07-16 CN claimed
US-20240107876-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-03-28 US claimed
US-20230301189-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-21 US claimed
WO-2023117836-A1 ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-06-29 WO claimed
WO-2023017856-A1 MIXED POWDER, METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT THAT USES MIXED POWDER, AND VAPOR DEPOSITION COMPOSITION 出光興産株式会社 2023-02-16 WO claimed
WO-2022183900-A1 ORGANIC LIGHT-EMITTING DEVICE HAVING THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL AS LIGHT-EMITTING LAYER MATERIAL 北京大学深圳研究生院 2022-09-09 WO claimed
US-20220231232-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-07-21 US claimed
WO-2022138107-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 2022-06-30 WO claimed
US-20220173318-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2022-06-02 US claimed
EP-1651639-B1 BENZOFURAN DERIVATIVES AND THEIR USE IN THE TREATMENT OF MICROBIAL INFECTIONS ARPIDA AG (CH) 2010-05-26 EP claimed
US-7524854-B2 Benzofuran derivatives and their use in the treatment of microbial infections ARPIDA AG (CH) 2009-04-28 US claimed
US-20060154943-A1 Benzofuran derivatives and their use in the treatment of microbial infections ARPIDA AG (CH) 2006-07-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250380610-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE LEF1, L1CAM, EMC1 SMN1; SMN2 3240/4885MEN1 934/4885SLC22A1 412/4885
US-20240107876-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SLC39A14, SLC39A3, SLC19A2 SMN1; SMN2 3509/4885MEN1 1571/4885SLC22A1 47/4885
US-20060154943-A1 Benzofuran derivatives and their use in the treatment of microbial infections DCXR, NLRP3, NISCH SMN1; SMN2 3544/4885MEN1 4151/4885SLC22A1 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.